Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Eichrom Technologies is a specialized chemical company that provides advanced separation and purification solutions for the nuclear medicine, environmental, and radiochemistry industries. Founded as a spin-off from Argonne National Laboratory, the company is the global leader in extraction chromatography resins, which are essential for the production of high-purity medical isotopes used in targeted cancer therapies. Their product portfolio includes a wide range of ion exchange and extraction resins designed to isolate specific radionuclides such as Actinium-225, Lutetium-177, and Strontium-90. In addition to manufacturing, Eichrom offers analytical services through its subsidiary, Impact Analytical, supporting the pharmaceutical and specialty chemical sectors. The company's technologies are critical components in the supply chain for next-generation radiopharmaceuticals and environmental monitoring programs worldwide.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Eichrom Technologies.